245 related articles for article (PubMed ID: 35437329)
1. Breast tumor microenvironment structures are associated with genomic features and clinical outcome.
Danenberg E; Bardwell H; Zanotelli VRT; Provenzano E; Chin SF; Rueda OM; Green A; Rakha E; Aparicio S; Ellis IO; Bodenmiller B; Caldas C; Ali HR
Nat Genet; 2022 May; 54(5):660-669. PubMed ID: 35437329
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
Li J; Wu J; Han J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer.
Lv J; Ren J; Zheng J; Zhang F; Han M
Dis Markers; 2022; 2022():5621441. PubMed ID: 35242245
[TBL] [Abstract][Full Text] [Related]
4. Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures.
Wang T; Li T; Li B; Zhao J; Li Z; Sun M; Li Y; Zhao Y; Zhao S; He W; Guo X; Ge R; Wang L; Ding D; Liu S; Min S; Zhang X
Front Immunol; 2022; 13():805184. PubMed ID: 35154121
[TBL] [Abstract][Full Text] [Related]
5. Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach.
Bareche Y; Buisseret L; Gruosso T; Girard E; Venet D; Dupont F; Desmedt C; Larsimont D; Park M; Rothé F; Stagg J; Sotiriou C
J Natl Cancer Inst; 2020 Jul; 112(7):708-719. PubMed ID: 31665482
[TBL] [Abstract][Full Text] [Related]
6. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor-positive breast cancer.
Brechbuhl HM; Xie M; Kopin EG; Han AL; Vinod-Paul K; Hagen J; Edgerton S; Owens P; Sams S; Elias A; Sartorius CA; Tan AC; Kabos P
Mol Carcinog; 2022 Mar; 61(3):359-371. PubMed ID: 34856027
[TBL] [Abstract][Full Text] [Related]
8. A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients.
Geng S; Fu Y; Fu S; Wu K
Front Immunol; 2022; 13():927565. PubMed ID: 36059555
[TBL] [Abstract][Full Text] [Related]
9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
10. The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer.
Zohair B; Chraa D; Rezouki I; Benthami H; Razzouki I; Elkarroumi M; Olive D; Karkouri M; Badou A
Front Immunol; 2023; 14():1201632. PubMed ID: 37753093
[TBL] [Abstract][Full Text] [Related]
11. Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.
He Q; Xue S; Wa Q; He M; Feng S; Chen Z; Chen W; Luo X
Medicine (Baltimore); 2021 Apr; 100(17):e25715. PubMed ID: 33907159
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer.
Kang BH; Jang BS; Kim IA
Breast Cancer Res Treat; 2023 Feb; 197(3):479-488. PubMed ID: 36515748
[TBL] [Abstract][Full Text] [Related]
13. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
[TBL] [Abstract][Full Text] [Related]
14. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
[TBL] [Abstract][Full Text] [Related]
15. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
Front Immunol; 2021; 12():657950. PubMed ID: 33936088
[TBL] [Abstract][Full Text] [Related]
16. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.
Bagaev A; Kotlov N; Nomie K; Svekolkin V; Gafurov A; Isaeva O; Osokin N; Kozlov I; Frenkel F; Gancharova O; Almog N; Tsiper M; Ataullakhanov R; Fowler N
Cancer Cell; 2021 Jun; 39(6):845-865.e7. PubMed ID: 34019806
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of imaging and transcriptomic data of the immune landscape associated with tumor metabolism in lung adenocarcinoma: Clinical and prognostic implications.
Choi H; Na KJ
Theranostics; 2018; 8(7):1956-1965. PubMed ID: 29556367
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer.
Song Y; Sun Y; Sun T; Tang R
Comb Chem High Throughput Screen; 2020; 23(5):381-391. PubMed ID: 32264809
[TBL] [Abstract][Full Text] [Related]
19. Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures.
Li J; Qiu J; Han J; Li X; Jiang Y
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360212
[TBL] [Abstract][Full Text] [Related]
20. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
